Table 1. Data sources.
| Traits | Sample size (cases/controls) | SNPs | Gender | Year | Data sources |
|---|---|---|---|---|---|
| Acute and subacute iridocyclitis (finn-b-H7_IRIDOACUTE) |
212,413 (3,126/209,287) | 16,380,353 | Males and Females | 2021 | FinnGen |
| Ankylosing spondylitis (finn-b-M13_ANKYLOSPON) |
166,144 (1,462/164,682) | 12,243,372 | Males and Females | 2021 | FinnGen |
| Coxarthrosis (finn-b-M13_ARTHTROSIS_COX) |
157,930 (10,709/147,221) | 12,243,487 | Males and Females | 2021 | FinnGen |
| Juvenile rheuma (finn-b-M13_JUVERHEU) |
147573 (352/147,221) | 12,243,324 | Males and Females | 2021 | FinnGen |
| Systemic lupus erythematosus (finn-b-M13_SLE) |
213683 (538/213,145) | 12,243,540 | Males and Females | 2021 | FinnGen |
| Spondyloarthritis (finn-b-SPONDYLOARTHRITIS) |
201,581 (3,037/198,544) | 16,380,410 | Males and Females | 2021 | FinnGen |
| Malignant neoplasm of kidney, except renal pelvis (finn-b-C3_KIDNEY_NOTRENALPELVIS) |
218,792 (971/217,821) | 16,380,403 | Males and Females | 2021 | FinnGen |